Lyell Immunopharma (LYEL.US) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

Shareholder Type

Institutions36.59%
VC/PE firms25.66%
Private companies17.56%
Public and others12.93%
Individuals & Insiders7.26%

Major Shareholders

Major Shareholders Latest
Shareholder
Arch Venture Partners, L.P.	13.25%	3.25M	0.67%	+0	06/30/2026
Innovative Cellular Therapeutics Holdings Limited	11.32%	2.77M	0.89%	-82.52K	07/27/2026
Gates Frontier, LLC	6.24%	1.53M	0.31%	+0	03/31/2026
Explore Investments LLC	6.24%	1.53M	0.31%	+0	03/31/2026
GSK Equity Investments, Limited	6.17%	1.51M	0.31%	+0	06/30/2026
Antonis Indianos	5.82%	1.43M	0.29%	+0	03/31/2026
Mwg Management Ltd.	4.11%	1.01M	0.21%	+0	03/31/2026
Vanguard Capital Management, LLC	3.59%	879.87K	0.14%	+74.79K	06/30/2026
Apoletto Limited	3.08%	754.70K	0.16%	+0	06/30/2026
BlackRock, Inc.	2.96%	724.34K	2.13%	+532.52K	06/30/2026
Decheng Capital LLC	2.82%	692.05K	0.14%	+0	06/30/2026
Almitas Capital LLC	2.37%	581.41K	0.10%	+3.60K	06/30/2026
Foresite Capital Management, LLC	1.94%	476.39K	3.53%	-801.09K	06/30/2026
Millennium Management LLC	1.50%	367.47K	0.47%	-91.43K	06/30/2026
Opaleye Management Inc.	1.40%	344.03K	1.06%	+264.93K	06/30/2026
venBio LLC	1.38%	337.70K	0.07%	+0	06/30/2026
Geode Capital Management, LLC	1.27%	310.64K	0.55%	+143.66K	06/30/2026
GV Management Company, LLC	1.20%	293.26K	0.06%	+0	06/30/2026
Richard KlausnerFounder & Executive Chairman	0.78%	190.56K	0.72%	-158.00K	06/10/2026
State Street Investment Management	0.76%	185.32K	0.45%	+112.80K	06/30/2026